Highlights
NASDAQ: ONCE       Spark Therap
Last Price Today's Change   Day's Range   Trading Volume
87.10   -0.89 (1.01%)  86.22 - 88.56  529,800

Overview

 
Avg Volume (4 weeks):384,900
4 Weeks Range:77.36 - 88.65
4 Weeks Price Volatility (%):
86.27%
52 Weeks Range:35.07 - 88.65
52 Weeks Price Volatility (%):
97.11%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Spark Therapeutics, Inc. is a gene therapy company. The Company focuses on treating orphan diseases. It has a pipeline of product candidates targeting multiple rare blinding conditions, hematologic disorders and neurodegenerative diseases. Its pipeline includes a product candidate targeting choroideremia (CHM), which is in a Phase I/II clinical trial and a product candidate for hemophilia A, which is in a Phase I/II clinical trial. Its product investigational candidate, voretigene neparvovec, is intended to treat a genetic blinding condition or inherited retinal disease (IRD). The programs targeting hematologic disorders include SPK-FIX, for which the lead product candidate, SPK-9001, is in a Phase I/II clinical trial for the treatment of hemophilia B, as well as SPK-FVIII for the treatment of hemophilia A. In its SPK-FVIII program for the treatment of hemophilia A, the Company has initiated a dose-escalating Phase I/II clinical trial for its lead product candidate, SPK-8011.

  Be the first to like this.
 


 

3136  4051  767  443 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 AMD 13.41-0.33 
 BAC 25.16+0.10 
 GE 24.75+0.43 
 XLF 25.46+0.06 
 SPY 249.39-0.67 
 VALE 10.32-0.27 
 F 11.72+0.01 
 GDX 23.21-0.29 
 SDRL 0.371-0.107 
 AAPL 153.39-2.68 
Partners & Brokers